Clinical Trials Microdosing Research and Development Treatment 
Cannabis Law Report
JULY 25, 2022
together with research collaborators at the University of Auckland , have received NZ$1.44 million ($650,000) in funding from New Zealand’s Health Research Council (HRC) to conduct a LSD microdosing trial in patients with Major Depressive Disorder (MDD). — MindBio Therapeutics (@MindBioTherap) July 10, 2022.
Cannabis Law Report
JULY 13, 2022
Their position as therapeutic practitioners, as well as their work in conducting the kind of clinical trials necessary to advance regulatory outcomes for psychedelic medicines, make them ideal partners in alignment with Optimi’s strategic goals.”. VANCOUVER, British Columbia, July 13, 2022 (GLOBE NEWSWIRE) — Optimi Health Corp. (
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JULY 9, 2022
For Jessica Thornton, who has lived with treatment-resistant depression since her senior year at high school, psychedelics represent a lifeline. Desperate to find any solution, she tried microdosing psilocybin mushrooms after researching the practice online. I felt as if I was in a constant battle with myself.
Cannabis Law Report
AUGUST 10, 2022
Researchers will explore whether the psychoactive effects are necessary to relieve treatment-resistant depression in adults. It’s clear that alternative treatment options are necessary to combat depression and other mental illnesses, which is where companies developing psychedelic-based treatments like Optimi Health Corp.
The Cannigma
DECEMBER 12, 2022
Now, psychedelic research is booming. And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders.
Cannabis Law Report
MARCH 3, 2022
Vincent and the Grenadines (SVG) is looking to position itself as one of the most progressive countries on the planet for psychedelic research. . If everything works out in the production and research phase, there is a clause in the license that will allow it to be expanded to clinical trials. and Europe.
The Cannigma
JUNE 24, 2021
These natural alternatives may also be effective as part of a daily “microdosing” regiment. In recent years, cannabis has been the subject of a tremendous amount of scientific research, and in 2020 there was a record number of scientific studies published on cannabis. Meditation and mindfulness. How CBD and cannabis products can help.
Expert insights. Personalized for you.
52 
Let's personalize your content